During the past decade, Sherbourne Medical Centre conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 5 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sherbourne Medical Centre" #1 sponsor was "Merz Pharmaceuticals GmbH" with 2 trials, followed by "P1vital Products Limited" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "BTG International Inc." with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sherbourne Medical Centre" #1 collaborator was "Alimentary Health Ltd" with 1 trials as a collaborator and "Encorium" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Sherbourne Medical Centre" are "Depression" (2 trials), "Subjective Tinnitus" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Atrial Fibrillation" (1 trials) and "Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Sherbourne Medical Centre" in a lesser frequency.

Most popular intervention types in "Sherbourne Medical Centre" are "Drug" (7 trials), "Device" (2 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Neramexane mesylate" (2 trials), "Angiotensin Therapeutic Vaccine plus CoVaccine HT™ adjuvant" (1 trials), "Bifidobacterium infantis 35624" (1 trials) and "CoVaccine HT™ adjuvant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sherbourne Medical Centre" are 9 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Sherbourne Medical Centre". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Sherbourne Medical Centre, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Sherbourne Medical Centre, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".